Treprostinil Ideogen 5 mg/mL, Infusionslösung
7680682620036
CH-68262
Infusionslösung
Associated product:
TREPROSTINIL Ideogen sol perf 5 mg/ml 20 ml
1 / 3
google
Article details
- Package size
- 1 x 20 ml
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Infusionslösung
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Konservierungsstoff (Conservateur) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
3.91 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 9441.50
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/11/2022
Authorization holder
IDEOGEN AG
8807 Freienbach
Authorization information
- Swissmedic authorization number
- 68262
- Drug name
- Treprostinil Ideogen, Infusionslösung
- Galenic form
- LSINF
- ATC Code
- B01AC21
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 07/04/2022
- Authorization expiration date
- 06/04/2027
- IT Number
- 02.07.1.
- Domain
- Human medicine
Package details
- Description (FR)
- TREPROSTINIL Ideogen sol perf 5 mg/ml 20 ml
- Description (DE)
- TREPROSTINIL Ideogen Inf Lös 5 mg/ml 20 ml
- Market launch
- 07/04/2022
- Narcotic (BTM)
- No
Original drug
Remodulin, Infusionslösung
GTIN: 7680561200014
CHF 2631.85